Candriam Luxembourg S.C.A. »

Halozyme Therapeutics shares owned by Candriam Luxembourg S.C.A.

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Candriam Luxembourg S.C.A. from 13F filings

Historical chart of Candriam Luxembourg S.C.A. investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Candriam Luxembourg S.C.A.

Quarter filed Position value Share count Share price at filing
2023-12-31 $691k 800 863.77
2023-09-30 $339k 400 847.82
2023-06-30 $666k 800 832.82
2023-03-31 $625k 800 780.58
2022-12-31 $2.8M 2.5k 1117.87